Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality?

Mechanisms of Ageing and Development

Volumn 158, Issue , 2016, Pages 53-61

  Feinstein, Lydia ^a,d   Douglas, Christian E ^a   Stebbins, Rebecca C ^a   Pawelec, Graham ^b   Simanek, Amanda M ^c   Aiello, Allison E ^a,d  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

Aging; Cytomegalovirus; Mortality; NHANES III; Socioeconomic status

Indexed keywords

ADULT; AGE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOCIAL STATUS; CYTOMEGALOVIRUS; EPIDEMIOLOGY; FOLLOW UP; MIDDLE AGED; SOCIOECONOMICS; UNITED STATES;

ADULT; AGE FACTORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84982170243     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.06.001     Document Type: Article

References (82)

1. Adler, N.E., Newman, K., Socioeconomic disparities in health: pathways and policies. Health Aff. 21:2 (2002), 60–76.
2. Aiello, A.E., Haan, M., Blythe, L., Moore, K., Gonzalez, J.M., Jagust, W., The influence of latent viral infection on rate of cognitive decline over 4 years. J. Am. Geriatr. Soc. 54:7 (2006), 1046–1054.
3. Plan and operation of the Third National Health and Nutrition Examination Survey 1988-94, Vital Health Stat 1. 1994 (32).
4. Barami, K., Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J. Clin. Neurosci. 17:7 (2010), 819–823.
5. Barnes, L.L., Capuano, A.W., Aiello, A.E., et al. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J. Infect. Dis. 211:2 (2015), 230–237.
6. Bate, S.L., Dollard, S.C., Cannon, M.J., Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin. Infect. Dis. 50:11 (2010), 1439–1447.
7. Berglund P.A., 2009. Getting the Most out of the SAS® Survey Procedures: Repeated Replication Methods, Subpopulation Analysis, and Missing Data Options in SAS® v9.2.
8. Binder, D.A., On the variances of asymptotically normal estimators from complex surveys. Int. Stat. Rev./Revue Int. Stat. 51:3 (1983), 279–292.
9. Braveman, P.A., Cubbin, C., Egerter, S., Williams, D.R., Pamuk, E., Socioeconomic disparities in health in the United States: what the patterns tell us. Am. J. Public Health 100:Suppl 1 (2010), S186–196.
10. Breslow, N.E., Discussion of professor cox's paper. J. R. Stat. Soc. Ser. B 34 (1972), 216–217.
11. Cannon, M.J., Schmid, D.S., Hyde, T.B., Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20:4 (2010), 202–213.
12. Caserta, M.T., O'Connor, T.G., Wyman, P.A., et al. The associations between psychosocial stress and the frequency of illness, and innate and adaptive immune function in children. Brain Behav. Immun. 22:6 (2008), 933–940.
13. Census Bureau, U.S., Current Population Survey Data on Educational Attainment. 2013 http://www.census.gov/hhes/socdemo/education/data/cps/index.html (accessed. 25.08.15.).
14. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:5 (1987), 373–383.
15. Chen, Y., Segers, S., Blaser, M.J., Association between Helicobacter pylori and mortality in the NHANES III study. Gut 62:9 (2013), 1262–1269.
16. Chetty, R., Stepner, M., Abraham, S., et al. The association between income and life expectancy in the United States, 2001–2014. JAMA, 2016, 2016.
17. Colugnati, F.A., Staras, S.A., Dollard, S.C., Cannon, M.J., Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect. Dis., 7, 2007, 71.
18. DeNavas-Walt, C., Proctor, B.D., Income and Poverty in the United States 2013 Current Population Reports., 2014, U.S. Census Bureau, Washington, DC.
19. Deaton, A., On death and money: history facts, and explanations. JAMA, 2016, 2016.
20. Derhovanessian, E., Maier, A.B., Beck, R., et al. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 185:8 (2010), 4618–4624.
21. Derhovanessian, E., Maier, A.B., Hahnel, K., et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J. Gen. Virol. 92:Pt 12 (2011), 2746–2756.
22. Dowd, J.B., Aiello, A.E., Socioeconomic differentials in immune response. Epidemiology 20:6 (2009), 902–908.
23. Dowd, J.B., Haan, M.N., Blythe, L., Moore, K., Aiello, A.E., Socioeconomic gradients in immune response to latent infection. Am. J. Epidemiol. 167:1 (2008), 112–120.
24. Dowd, J.B., Aiello, A.E., Alley, D.E., Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 137:1 (2009), 58–65.
25. Dowd, J.B., Zajacova, A., Aiello, A., Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Soc. Sci. Med. 68:4 (2009), 699–707.
26. Dowd, J.B., Albright, J., Raghunathan, T.E., Schoeni, R.F., Leclere, F., Kaplan, G.A., Deeper and wider: income and mortality in the USA over three decades. Int. J. Epidemiol. 40:1 (2011), 183–188.
27. Dowd, J.B., Palermo, T.M., Aiello, A.E., Family poverty is associated with cytomegalovirus antibody titers in U.S. children. Health Psychol. 31:1 (2012), 5–10.
28. Furman, D., Jojic, V., Sharma, S., et al. Cytomegalovirus infection enhances the immune response to influenza. Sci. Trans. Med., 7(281), 2015 (281ra243).
29. Geronimus, A.T., Bound, J., Colen, C.G., Excess black mortality in the United States and in selected black and white high-poverty areas, 1980–2000. Am. J. Public Health 101:4 (2011), 720–729.
30. Gkrania-Klotsas, E., Langenberg, C., Sharp, S.J., Luben, R., Khaw, K.T., Wareham, N.J., Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort. Clin. Infect. Dis. 56:10 (2013), 1421–1427.
31. Greenland, S., Pearl, J., Robins, J.M., Causal diagrams for epidemiologic research. Epidemiology 10:1 (1999), 37–48.
32. Hadrup, S.R., Strindhall, J., Køllgaard, T., et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176:4 (2006), 2645–2653 Baltimore, Md.: 1950.
33. Harkins, L., Volk, A.L., Samanta, M., et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:9345 (2002), 1557–1563.
34. Harrison, G., Cytomegalovirus. Cherry, J., Demmler-Harrison, G.J., Kaplan, S.L., Steinbach, W.J., Hotez, P., (eds.) Feigin and Cherry's Textbook of Pediatric Infectious Disease, 7th ed., 2014, Elsevier Saunders, Philadelphia, 1969.
35. Herbein, G., Kumar, A., The oncogenic potential of human cytomegalovirus and breast cancer. Front. Oncol., 4, 2014, 230.
36. Howe, C.J., Cole, S.R., Westreich, D.J., Greenland, S., Napravnik, S., Eron, J.J. Jr., Splines for trend analysis and continuous confounder control. Epidemiology 22:6 (2011), 874–875.
37. Hummer, R.A., Hernandez, E.M., The effect of educational attainment on adult mortality in the United States. Popul. Bull. 68:1 (2013), 1–16.
38. Itzhaki, R.F., Wozniak, M.A., Appelt, D.M., Balin, B.J., Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol. Aging 25:5 (2004), 619–627.
39. Khan, N., Shariff, N., Cobbold, M., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169:4 (2002), 1984–1992 Baltimore, Md.: 1950.
40. Kristenson, M., Eriksen, H.R., Sluiter, J.K., Starke, D., Ursin, H., Psychobiological mechanisms of socioeconomic differences in health. Soc. Sci. Med. 58:8 (2004), 1511–1522.
41. Krueger, P.M., Tran, M.K., Hummer, R.A., Chang, V.W., Mortality attributable to low levels of education in the United States. PLoS One, 10(7), 2015, e0131809.
42. Lange, T., Hansen, J.V., Direct and indirect effects in a survival context. Epidemiology 22:4 (2011), 575–581.
43. Liu, R., Moroi, M., Yamamoto, M., et al. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int. Heart J. 47:4 (2006), 511–519.
44. Meyer, P.A., Penman-Aguilar, A., Campbell, V.A., et al. Conclusion and future directions: CDC health disparities and inequalities report − United States, 2013: morbidity and mortality weekly report. Surveill. Summ. 62:Suppl 3 (2013), 184–186.
45. Michaelis, M., Doerr, H.W., Cinatl, J., The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11:1 (2009), 1–9.
46. Mocchegiani, E., Giacconi, R., Cipriano, C., Malavolta, M., NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J. Clin. Immunol. 29:4 (2009), 416–425.
47. Mocchegiani, E., Costarelli, L., Giacconi, R., et al. Micronutrient-gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review. Mech. Ageing Dev. 136:-137 (2014), 29–49.
48. Muennig, P., Fiscella, K., Tancredi, D., Franks, P., The relative health burden of selected social and behavioral risk factors in the United States: implications for policy. Am. J. Public Health 100:9 (2010), 1758–1764.
49. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. Hyattsville (MD) 2012.
50. National Center for Health Statistics. Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-1994). Hyattsville, Maryland October 1996.
51. National Center for Health Statistics. Analytic Guidelines for NCHS 2011 Linked Mortality Files. Hyattsville, MarylandSeptember 2013.
52. National Center for Health Statistics, Office of Analysis and Epidemiology, Public-use Linked Mortality File. 2015 http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm.
53. National Research Counscil Panel on Race, Ethnicity, and health in later life. Race/Ethnicity, socioeconomic status, and health. Anderson, N., Bulatao, R., Cohen, B., (eds.) Critical Perspectives on Racial and Ethnic Differences in Health in Late Life, 2004, National Academies Press (US), Washington (DC).
54. Nguyen, Q.C., Osypuk, T.L., Schmidt, N.M., Glymour, M.M., Tchetgen, E.J., Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting. Am. J. Epidemiol. 181:5 (2015), 349–356.
55. Olshansky, S.J., Antonucci, T., Berkman, L., et al. Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff. 31:8 (2012), 1803–1813.
56. Pass, R.F., Zhang, C., Evans, A., et al. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360:12 (2009), 1191–1199.
57. Pawelec, G., Derhovanessian, E., Role of CMV in immune senescence. Virus Res. 157:2 (2011), 175–179.
58. Pawelec, G., Derhovanessian, E., Larbi, A., Strindhall, J., Wikby, A., Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 19:1 (2009), 47–56.
59. Pawelec, G., Immunosenenescence: role of cytomegalovirus. Exp. Gerontol., 2013.
60. Rao, J.N.K., Scott, A.J., On chi-Squared tests for multiway contingency tables with cell proportions estimated from survey data. Annal. Stat. 12:1 (1984), 46–60.
61. Rask, K., O'Malley, E., Druss, B., Impact of socioeconomic, behavioral and clinical risk factors on mortality. J. Public Health 31:2 (2009), 231–238.
62. Rector, J.L., Dowd, J.B., Loerbroks, A., et al. Consistent associations between measures of psychological stress and CMV antibody levels in a large occupational sample. Brain Behav. Immun. 38 (2014), 133–141.
63. Roberts, E.T., Haan, M.N., Dowd, J.B., Aiello, A.E., Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 172:4 (2010), 363–371.
64. Sabanayagam, C., Shankar, A., Income is a stronger predictor of mortality than education in a national sample of US adults. J. Health Popul. Nutr. 30:1 (2012), 82–86.
65. Samanta, M., Harkins, L., Klemm, K., Britt, W.J., Cobbs, C.S., High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 170:3 (2003), 998–1002.
66. Sansoni, P., Vescovini, R., Fagnoni, F.F., et al. New advances in CMV and immunosenescence. Exp. Gerontol. 55 (2014), 54–62.
67. Sarid, O., Anson, O., Yaari, A., Margalith, M., Human cytomegalovirus salivary antibodies as related to stress. Clin. Lab. 48:5–6 (2002), 297–305.
68. Savva, G.M., Pachnio, A., Kaul, B., et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell. 12:3 (2013), 381–387.
69. Schisterman, E.F., Cole, S.R., Platt, R.W., Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20:4 (2009), 488–495.
70. Schmaltz, H.N., Fried, L.P., Xue, Q.L., Walston, J., Leng, S.X., Semba, R.D., Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J. Am. Geriatr. Soc. 53:5 (2005), 747–754.
71. Simanek, A.M., Dowd, J.B., Aiello, A.E., Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int. J. Epidemiol. 38:3 (2009), 775–787.
72. Simanek, A.M., Dowd, J.B., Pawelec, G., Melzer, D., Dutta, A., Aiello, A.E., Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One, 6(2), 2011, e16103.
73. Simanek, A.M., Cheng, C., Yolken, R., Uddin, M., Galea, S., Aiello, A.E., Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology 50 (2014), 139–148.
74. Simanek, A.M., Dowd, J.B., Zajacova, A., Aiello, A.E., Unpacking the ‘black box' of total pathogen burden: is number or type of pathogens most predictive of all-cause mortality in the United States?. Epidemiol. Infect. 143:12 (2015), 2624–2634.
75. Soderberg-Naucler, C., Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J. Intern. Med. 259:3 (2006), 219–246.
76. Sorlie, P.D., Nieto, F.J., Adam, E., Folsom, A.R., Shahar, E., Massing, M., A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch. Intern. Med. 160:13 (2000), 2027–2032.
77. Staras, S.A., Dollard, S.C., Radford, K.W., Flanders, W.D., Pass, R.F., Cannon, M.J., Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin. Infect. Dis. 43:9 (2006), 1143–1151.
78. Suresh, S., Sabanayagam, C., Shankar, A., Socioeconomic status, self-rated health, and mortality in a multiethnic sample of US adults. Journal of Epidemiology/Japan Epidemiological Association. 21:5 (2011), 337–345.
79. Tarter, K.D., Simanek, A.M., Dowd, J.B., Aiello, A.E., Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J. Infect. Dis. 209:6 (2014), 837–844.
80. Turner, J.E., Campbell, J.P., Edwards, K.M., et al. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age 36:1 (2014), 287–297.
81. Tyznik, A.J., Verma, S., Wang, Q., Kronenberg, M., Benedict, C.A., Distinct requirements for activation of NKT and NK cells during viral infection. J. Immunol. 192:8 (2014), 3676–3685.
82. Wang, G.C., Kao, W.H., Murakami, P., et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 171:10 (2010), 1144–1152.